131I shortage — FR supply status & alternatives

131I

—

🇦🇺 AUST R 22800 · ANSTO t/a ANSTO Health

In supply · Australia

Norcholesterol iodé CIS Bio International

In supply · 🇦🇺 Australia · short in🇫🇷 FR

In supply in Australia

Reading today’s signals…

✓ Can I substitute?

Per normal rules

Confirm with prescriber

⇄ Best alternative

None listed

refer to prescriber

◷ Expected back

No estimate

No estimate provided

Product attributes reference data we hold

Active ingredient (INN)	131I
Brand names	Norcholesterol iodé CIS Bio International
Therapeutic category	Auto-created by Agence nationale de sécurité du médicament — Disponibilité scraper

Controlled substance	No

Marketing-authorisation holders	ANSTO t/a ANSTO Health, ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.

Registrations on file	3

Patient information leaflet (PIL)	Not on file

Summary of product characteristics (SPC)	Not on file

Trade price 🇦🇺 Australia · awaiting price ingest

🇦🇺 AU

Ex-manufacturer

—

Dispensed (DPMQ)

—

Pack

—

Not yet captured for Australia

Official pricing isn’t on file for this market yet. PBS (Australia), NHS Drug Tariff (United Kingdom) and CMS NADAC (United States) feeds are prioritised; this panel populates automatically once the data lands.

Substitution pathways 🇦🇺 Australia · TGA

—

No substitution instrument in force

Dispense per normal rules, or refer to the prescriber. No active SSSI/S19A instrument detected for this medicine.

How long have past shortages lasted? from 1 resolved event

◷

~0 month

Historical pattern from resolved shortage records — not a prediction of this event.

Global API supply base 🇺🇸 FDA Drug Master Files · active Type II

1 API manufacturer

Manufacturers with an active Type II Drug Master File — i.e. cleared to supply this active ingredient into the US market. A proxy for how concentrated the global manufacturing base is.

Very high concentration risk

Telix Pharmaceuticals Us INC

Country of manufacture not yet mapped · Source: FDA List of Drug Master Files

Shortage status by regulator official notices

🇫🇷

France

ANSM · 3d ago

High

Verified timeline regulator events

🇫🇷 16 June 2026

Shortage resolved

🇫🇷 11 Feb 2026

high reported

Sources official regulators

🇫🇷

ANSM

verified 14h ago

verify ↗

Registration recordmarketing-authorisation holders

Registrations & marketing-authorisation holders3 registrations · 2 MA holders

Product	Strength	Form	Market	MA holder	Status
ANSTO Health Sodium Iodide	—	—	🇦🇺 AU	ANSTO t/a ANSTO Health	Active
Sodium iodide	—	—	🇦🇺 AU	ANSTO t/a ANSTO Health	Active
Sodium Iodide	—	solution	🇨🇦 CA	ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD.	Active

Mederti Drug Report

Generated 2 July 2026 · Australia market · 1 regulatory source

For health-professional reference only. Mederti aggregates shortage and substitution information from official regulatory sources. It is not clinical advice and data may be incomplete or delayed. Confirm any substitution or supply decision against the primary regulator source, the prescriber, and current clinical references (e.g. AMH) before acting. Terms.